NO931675L - Nye n-aralkyl- og n-heteroaralkylaminoalkanfosfinsyrer - Google Patents

Nye n-aralkyl- og n-heteroaralkylaminoalkanfosfinsyrer

Info

Publication number
NO931675L
NO931675L NO93931675A NO931675A NO931675L NO 931675 L NO931675 L NO 931675L NO 93931675 A NO93931675 A NO 93931675A NO 931675 A NO931675 A NO 931675A NO 931675 L NO931675 L NO 931675L
Authority
NO
Norway
Prior art keywords
aralkyl
aliphatic
nootropic
heteroaryl
acids
Prior art date
Application number
NO93931675A
Other languages
English (en)
Other versions
NO931675D0 (no
Inventor
Stuart John Mickel
Wolfgang Froestl
Pascal Furet
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO931675D0 publication Critical patent/NO931675D0/no
Publication of NO931675L publication Critical patent/NO931675L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6527—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07F9/653—Five-membered rings
    • C07F9/65306—Five-membered rings containing two nitrogen atoms
    • C07F9/65318—Five-membered rings containing two nitrogen atoms having the two nitrogen atoms in positions 1 and 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/301—Acyclic saturated acids which can have further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/58—Pyridine rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having three nitrogen atoms as the only ring hetero atoms
    • C07F9/6518—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6524—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having four or more nitrogen atoms as the only ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6527—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07F9/653—Five-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Alcoholic Beverages (AREA)
  • Confectionery (AREA)

Abstract

Det er beskrevet N-aralkyl- og N-heteroaralkylamlno- alkanfosfinsyrer med formel I hvor R betyr en allfatisk, cykloallfatisk, cyklo- allfatlsk-allfatisk, arallfatlsk eller heteroaryl- allfatlsk rest med minst 2 C-atomer, R} betyr hydrogen eller hydroksy, R2 betyr en med direkte eller over en Spacer bundet, eventuelt funksjonelt avledet karboksy- substltuert arallfatlsk eller heteroarylallfatisk rest og R3 betyr hydrogen, laverealkyl eller en gruppe R2, og deres salter. Forbindelsene oppviser verdifulle nootrope og antiepileptiske egenskaper og kan anvendes for fremstilling av et nootropt eller antiepileptisk legemiddel.
NO93931675A 1992-05-08 1993-05-07 Nye n-aralkyl- og n-heteroaralkylaminoalkanfosfinsyrer NO931675L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH148092 1992-05-08

Publications (2)

Publication Number Publication Date
NO931675D0 NO931675D0 (no) 1993-05-07
NO931675L true NO931675L (no) 1993-11-09

Family

ID=4211459

Family Applications (1)

Application Number Title Priority Date Filing Date
NO93931675A NO931675L (no) 1992-05-08 1993-05-07 Nye n-aralkyl- og n-heteroaralkylaminoalkanfosfinsyrer

Country Status (18)

Country Link
US (2) US5332729A (no)
EP (1) EP0569333B1 (no)
JP (1) JP3243056B2 (no)
KR (1) KR940005649A (no)
AT (1) ATE175415T1 (no)
AU (1) AU662404B2 (no)
CA (1) CA2095708C (no)
DE (1) DE59309265D1 (no)
ES (1) ES2128409T3 (no)
FI (1) FI932028A7 (no)
GR (1) GR3029899T3 (no)
HU (1) HUT64079A (no)
IL (1) IL105628A0 (no)
NO (1) NO931675L (no)
NZ (1) NZ247561A (no)
PH (1) PH30222A (no)
TW (1) TW224966B (no)
ZA (1) ZA933206B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5457095A (en) * 1984-10-12 1995-10-10 Ciba-Geigy Corporation Substituted propane-phosponous acid compounds
IL114631A (en) * 1990-06-22 1998-12-06 Novartis Ag Anti-epileptic compositions containing gabab- antagonistic compounds
EP0767174A1 (de) * 1991-11-21 1997-04-09 Ciba-Geigy Ag Neue Aminoalkanphosphinsäuren und ihre Salze
WO1997011953A1 (en) * 1995-09-28 1997-04-03 Novartis Ag Novel hydroxylated and alkoxylated n- and/or p-aralkylphosphinic acid derivatives
CA2254862A1 (en) * 1996-05-30 1997-12-11 Novartis Ag Metabotropic gaba[b] receptors, receptor-specific ligands and their uses
US7119189B2 (en) 1997-03-19 2006-10-10 Novartis Ag Metabotropic GABA [B] receptors, receptor-specific ligands and their uses
GB9906882D0 (en) * 1999-03-25 1999-05-19 Novartis Ag Organic compounds
US7319095B2 (en) * 1999-12-09 2008-01-15 Astrazeneca Ab Use of GABAB receptor agonists
SE9904508D0 (sv) * 1999-12-09 1999-12-09 Astra Ab New compounds
ATE448193T1 (de) * 2002-01-18 2009-11-15 Merck & Co Inc ßN-(BENZYL)AMINOALKYL CARBOXYLATE, PHOSPHINATE, PHOSPHONATE UND TETRAZOLE ALS EDG REZEPTORAGONISTENß
AR045794A1 (es) * 2003-09-23 2005-11-16 Aventis Pharma Inc Procedimiento para preparar derivados de acido 3- amino-2- hidroxipropilfosfinico
GB0327186D0 (en) * 2003-11-21 2003-12-24 Novartis Ag Organic compounds
AU2005244867A1 (en) * 2004-05-14 2005-12-01 The Johns Hopkins University Method for improving cognitive function by co-administration of a GABAB receptor antagonist and an acetylcholinesterase inhibitor
WO2006050472A2 (en) * 2004-11-03 2006-05-11 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs of 3-aminopropylphosphonous and -phosphinic acids
WO2006050471A2 (en) * 2004-11-03 2006-05-11 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs of sulfinic acids, methods of synthesis, and use
WO2008033572A1 (en) * 2006-09-15 2008-03-20 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs, methods of synthesis and use

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3493639A (en) * 1965-10-27 1970-02-03 Shell Oil Co Process for producing pentavalent phosphorus derivatives
JPS4714129Y1 (no) * 1969-06-11 1972-05-22
DE2032712C3 (de) * 1970-07-02 1978-10-19 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von w-Amino-alkanphosphonsäure bzw.- phosphinsäurederivaten
DE2440239A1 (de) * 1974-08-22 1976-03-04 Hoechst Ag Innere ammoniumsalze von phosphinsaeuren
JPS5463024A (en) * 1977-10-27 1979-05-21 Fujisawa Pharmaceut Co Ltd 3-(n-formyl-n-hydroxyamino)-2(r)-hydroxypropyl-phosphonic acid, its preparation, and its use
EP0093081B1 (de) * 1982-04-23 1986-03-19 Ciba-Geigy Ag Herbizide und pflanzenwuchsregulierende Mittel
US4536355A (en) * 1982-10-08 1985-08-20 Zoecon Corporation Phenoxyphenylaminoalkylphosphinates useful in weed control
GB8425872D0 (en) * 1984-10-12 1984-11-21 Ciba Geigy Ag Chemical compounds
FR2572078B1 (fr) * 1984-10-24 1988-07-15 Inst Francais Du Petrole Phosphobetaines neutres, leur preparation et leur application a la recuperation assistee du petrole
USD302521S (en) 1986-03-13 1989-08-01 Grinde James E Dual compartment container with measurement indicator
US5190933A (en) * 1987-12-04 1993-03-02 Ciba-Geigy Corporation Substituted propane-phosphinic acid compounds
GB8728483D0 (en) * 1987-12-04 1988-01-13 Ciba Geigy Ag Chemical compounds
GB8820266D0 (en) * 1988-08-26 1988-09-28 Smith Kline French Lab Compounds
US5212164A (en) * 1988-08-29 1993-05-18 E. R. Squibb & Sons, Inc. Phosphorus-containing squalene synthetase inhibitors
US5190934A (en) * 1989-06-03 1993-03-02 Ciba-Geigy Corporation P-subsituted propane-phosphinic acid compounds
IL114631A (en) * 1990-06-22 1998-12-06 Novartis Ag Anti-epileptic compositions containing gabab- antagonistic compounds
EP0767174A1 (de) * 1991-11-21 1997-04-09 Ciba-Geigy Ag Neue Aminoalkanphosphinsäuren und ihre Salze
GB9125615D0 (en) * 1991-12-02 1992-01-29 Wyeth John & Brother Ltd Amines

Also Published As

Publication number Publication date
FI932028L (fi) 1993-11-09
IL105628A0 (en) 1993-09-22
ES2128409T3 (es) 1999-05-16
NZ247561A (en) 1995-07-26
NO931675D0 (no) 1993-05-07
JPH0632793A (ja) 1994-02-08
FI932028A7 (fi) 1993-11-09
TW224966B (no) 1994-06-11
CA2095708A1 (en) 1993-11-09
CA2095708C (en) 2005-12-06
JP3243056B2 (ja) 2002-01-07
DE59309265D1 (de) 1999-02-18
HUT64079A (en) 1993-11-29
AU3711293A (en) 1993-11-11
EP0569333B1 (de) 1999-01-07
EP0569333A3 (no) 1994-04-06
KR940005649A (ko) 1994-03-22
ZA933206B (en) 1993-11-08
FI932028A0 (fi) 1993-05-05
GR3029899T3 (en) 1999-07-30
HU9301332D0 (en) 1993-09-28
AU662404B2 (en) 1995-08-31
US5424441A (en) 1995-06-13
US5332729A (en) 1994-07-26
PH30222A (en) 1997-02-05
ATE175415T1 (de) 1999-01-15
EP0569333A2 (de) 1993-11-10

Similar Documents

Publication Publication Date Title
NO931675L (no) Nye n-aralkyl- og n-heteroaralkylaminoalkanfosfinsyrer
ES2115665T3 (es) Derivado de triterpeno.
MY124586A (en) (benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties
ES2056913T3 (es) Derivados heterociclicos n-substituidos por el grupo benzhidrilo; su preparacion y su aplicacion.
DK0514282T3 (da) Nye alkylaminomercaptoalkylamider eller kosmetisk acceptable salte deraf og deres anvendelse som reduktionsmidler ved en fremgangsmåde til permanent formforandring af hår
EP0348341A3 (de) Aminoalkylindole, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate
BR9612099A (pt) Processo para preparar um composto derivado de piperidina, regioisÈmero, processo para preparar um regioisÈmero, derivado de ácido 4-( alfa,alfa, di-substuìdo) toluico e 4- (alfa, alfa-di-não substitìdo) toluico.
AU660469B2 (en) Pharmacologically active hydrazine derivatives and processes for the preparation thereof
ATE164582T1 (de) 1-methylcarbapenemderivate und verfahren zu ihrer herstellung
ES8301927A1 (es) Procedimiento de preparacion de acidos azabiciclohexano car-boxilicos y de sus sales
ES2011427A4 (es) Derivados de oxina de octahidronaftaleno para inhibicion de la sintesis del colesterol, procesos para su preparacion y composiciones que los contienen.
DE69203551D1 (de) Biologisch abbaubarer Copolyester von 4-Hydroxyprolin und diesen enthaltende pharmazeutische Zusammensetzung.
ES543154A0 (es) Metodo de preparar un derivado de acido b-carbolin-3-carbo- xilico
NO933170L (no) Heterocykliske forbindelser
GEP19981300B (en) 1,8-benzonaphthyridine Derivatives, Method for its Production, Intermidiate Compositions and those Based on 1,8-Benzonaphthyridine Derivatives.
RO87991A (ro) Procedeu pentru prepararea unor esteri tiazolidinici substituiti ai unor acizi minerali
DE69915623D1 (de) 2-aminothiazol-kondensierte 2-aminoindane und 2-aminotetraline, sowie deren verwendung
ES8407023A1 (es) Un procedimiento para la preparacion de 4-(3-trifluormetilfenil-1,2,3,6-tetrahidropiridinas
EP0390305A3 (en) Diester and keto-ester derivatives of polyhydroxy compounds and production thereof
ATE202100T1 (de) Triazolderivate
CA2027542A1 (en) Uv-absorbing cyclic enaminoketones
AU7332996A (en) Therapeutics for thrombocytopenia
DE58901277D1 (de) Substituierte 3-aminosydnonimine, verfahren zu ihrer herstellung und ihre verwendung.
ATE195311T1 (de) Phenoxyethylamin-derivate mit hoher affinität fur den 5-ht1a-rezeptor, verfahren zu ihrer herstellung, ihre verwendung als medikamente und sie enthaltende pharmazeutische zusammensetzungen
NO932002L (no) Nye tiosemikarbazonsyreestere